Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells-Reference-Cited by-同舟云学术

Activated protein C therapy slows ALS-like disease in mice by transcriptionally inhibiting SOD1 in motor neurons and microglia cells

Published:2009-10-19 Issue: Volume: Page:
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Zhong Zhihui,Ilieva Hristelina,Hallagan Lee,Bell Robert,Singh Itender,Paquette Nicole,Thiyagarajan Meenakshisundaram,Deane Rashid,Fernandez Jose A.,Lane Steven,Zlokovic Anna B.,Liu Todd,Griffin John H.,Chow Nienwen,Castellino Francis J.,Stojanovic Konstantin,Cleveland Don W.,Zlokovic Berislav V.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference64 articles.

1. The cytoprotective protein C pathway

2. Gene Expression Profile of Antithrombotic Protein C Defines New Mechanisms Modulating Inflammation and Apoptosis

3. Protease-activated Receptor-1 Signaling by Activated Protein C in Cytokine-perturbed Endothelial Cells Is Distinct from Thrombin Signaling

4. Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C Pathway

5. Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular and molecular mechanisms of the blood–brain barrier dysfunction in neurodegenerative diseases;Fluids and Barriers of the CNS;2024-07-19

2. Characterizing Modulators of Protease-activated Receptors with a Calcium Mobilization Assay Using a Plate Reader;Journal of Visualized Experiments;2024-05-24

3. Thrombomodulin reduces α-synuclein generation and ameliorates neuropathology in a mouse model of Parkinson’s disease;Cell Death Discovery;2024-04-08

4. Cellular and Noncellular Approaches for Repairing the Damaged Blood–CNS–Barrier in Amyotrophic Lateral Sclerosis;Cells;2024-02-29

5. Cytoprotective E-WE thrombin reduces disease severity in a murine model of relapsing-remitting multiple sclerosis;American Journal of Physiology-Cell Physiology;2024-01-01